Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: opalapril who wrote (7977)	12/8/1998 6:58:00 AM
From: celeryroot.com	Respond to of 17367

I find your reasoning way off. beter go back and reserch. Xoma will still be located in US. Bermuda is under UK rule.

To: opalapril who wrote (7977)	12/8/1998 10:16:00 AM
From: aknahow	Read Replies (1) \| Respond to of 17367

opalapril, I fully support the concept of a change in domicile, for any corporation in a similar situation where foreign earning might become a significant part of the whole. This is a compelling concept. I do not see the corporation escaping from tax on U.S. earnings. But, I have said and continue to say read the prospectus on any issue. For me it answered the major question, which was, "Why don't the big corporations do this?" Now I realize that their asset value makes it impossible." Yet I see that Amgen established three subsidiaries in Bermuda. does this make them an evil company? Not in my book. We have seen a new issue, up close an personal. It caused you some discomfort. I can only say think about the issue and prepare yourself to see this concept used again and again. If it produces short term weakness due to misunderstanding it might provide opportunities.

To: opalapril who wrote (7977)	12/8/1998 11:12:00 AM
From: Bluegreen	Read Replies (2) \| Respond to of 17367

Opal, thanks for your response. I had no idea you held such disdain for this company. I'm sure if there was a sinister plot under foot we would have been warned by Murphy, McCamant, Prohost or Taipan. Do you have any idea how highly regarded Xoma is among the above newsletters? I think you have to go by what expert opinion tells you. When I see the years of expert opinion behind the above FOUR, yes FOUR different newsletters I listen. When Lehman Bros. talks, you might want to take their advice! Remember it was by Lehman Bros. advice to move domicle. Some more things you might use to compute your morality equation. Xoma came up with bringing BPI to market, not a major pharma. Xoma is doing great work with Neuprex WITHOUT a partner. Xoma is not making widgets. Only my opinions and I voted YES.